CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has appointed Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer. “The addition of these two executives represents our ongoing commitment to accelerate impactful cell therapies reaching patients,” said Jason Bock, CEO of CTMC. Amy Hay, Chief Business Officer In the newly created role of Chief Business Officer, Hay is responsible for developing and executing the overall business strategy for...